FDA Warns: Hidden Deficiency Makes Cancer Drugs a Ticking Time Bomb
Published Date: 5/20/2025
Notice
Summary
The FDA wants to hear from the public about a condition called DPD deficiency that can affect how people handle certain cancer drugs, like fluorouracil and capecitabine. This is important because some patients might have serious side effects if they have this deficiency. The FDA is opening a comment period now to gather info and improve safety, with no immediate cost changes announced.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in